Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE
Report ID | 7392 |
Drug Identification Number | 02408090 |
Brand name | MYLAN-BUPRENORPHINE/NALOXONE |
Common or Proper name | BUPRENORPHINE/NALOXONE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUPRENORPHINE NALOXONE |
Strength(s) | 2MG 0.5MG |
Dosage form(s) | TABLET |
Route of administration | SUBLINGUAL |
Packaging size | 100BT |
ATC code | N07BC |
ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-06-26 |
Estimated end date | Unknown |
Actual end date | 2019-09-17 |
Shortage status | Resolved |
Updated date | 2019-09-18 |
Company comments | discontinued in ID 94044. Last lot 3085355 exp 2019-05-31 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v103 | 2018-03-01 | English | Compare |
v102 | 2018-02-27 | French | Compare |
v101 | 2018-02-27 | English | Compare |
v100 | 2018-02-24 | English | Compare |
v99 | 2018-02-23 | French | Compare |
v98 | 2018-02-23 | English | Compare |
v97 | 2018-02-21 | English | Compare |
v96 | 2018-02-16 | French | Compare |
v95 | 2018-02-16 | English | Compare |
v94 | 2018-02-15 | English | Compare |
v93 | 2018-02-12 | French | Compare |
v92 | 2018-02-12 | English | Compare |
v91 | 2018-02-09 | French | Compare |
v90 | 2018-02-09 | English | Compare |
v89 | 2018-02-08 | French | Compare |
v88 | 2018-02-08 | English | Compare |
v87 | 2018-02-08 | English | Compare |
v86 | 2018-02-05 | French | Compare |
v85 | 2018-02-05 | English | Compare |
v84 | 2018-02-02 | French | Compare |